Skip to Content

quinuclidinyl benzilate

Pronunciation: kwi-nuk'li-din'il ben'zi-lat

Definition: A highly potent anticholinergic agent exhibiting 50- to 100-fold greater potency over atropine in binding with and blocking muscarinic cholinergic receptors. Originally developed as a potential military incapacitating agent, it is currently extensively used as a radioactive agent (usually tritiated —H3 —QNB) to identify and label muscarinic receptors in pharmacologic studies.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.

Hide